Uppsala, Sweden

Carl Rosenfeld

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Q-Linea Ab. Active years: 2025.


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Carl Rosenfeld

Introduction

Carl Rosenfeld is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of analysis instruments, particularly with his innovative designs that enhance sample preparation processes. His work is recognized for its practical applications in various scientific and industrial settings.

Latest Patents

Rosenfeld holds a patent for an analysis instrument and sample preparation cartridge. This instrument features a cartridge bay designed to receive a sample preparation cartridge. It includes a controllable heater for heating samples, a first temperature sensor to monitor the heater's temperature, and a second temperature sensor to monitor the sample's temperature. This invention showcases his commitment to improving analytical techniques.

Career Highlights

Throughout his career, Carl Rosenfeld has been associated with Q-linea AB, a company known for its advancements in diagnostic solutions. His role at Q-linea has allowed him to contribute to the development of innovative technologies that address critical needs in the healthcare sector.

Collaborations

Rosenfeld has worked alongside talented colleagues, including Anders Lind and Henrik Söderström. Their collaborative efforts have fostered an environment of innovation and creativity, leading to the development of cutting-edge solutions in their field.

Conclusion

Carl Rosenfeld's contributions to the field of analysis instruments exemplify the impact of innovation in scientific research. His patent and work at Q-linea AB highlight his dedication to advancing technology for better analytical processes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…